Ubiquitin-specific Cysteine Protease 2a (USP2a) Regulates the Stability of Aurora-A

被引:58
作者
Shi, Yan [1 ]
Solomon, Larry R. [1 ]
Pereda-Lopez, Ana [1 ]
Giranda, Vincent L. [1 ]
Luo, Yan [1 ]
Johnson, Eric F. [1 ]
Shoemaker, Alexander R. [1 ]
Leverson, Joel [1 ]
Liu, Xuesong [1 ]
机构
[1] Abbott Labs, Dept Canc Res, Abbott Pk, IL 60064 USA
关键词
FATTY-ACID SYNTHASE; DEUBIQUITINATING ENZYME USP2A; PROSTATE-CANCER; P53; PATHWAY; B KINASE; CELLS; AMPLIFICATION; EXPRESSION;
D O I
10.1074/jbc.M111.231498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitin/proteasome pathway plays critical roles in virtually all aspects of cell biology. Enzymes of the ubiquitin pathway add (ligases) or remove (deubiquitinases) ubiquitin tags to or from their target proteins in a selective fashion. USP2a is a member of a subfamily of deubiquitinases, called ubiquitin-specific cysteine proteases (USPs). Although USP2a has been reported to be a bona fide oncogene that regulates the stability of MDM2, MDMX, and FAS, it is likely that there are other unidentified substrates for USP2a. In this study, we show that USP2a mediates mitotic progression by regulating the stability of Aurora-A. Through cell-based screening of a USP siRNA library, we discovered that knockdown of USP2a reduced the protein levels of Aurora-A. USP2a interacts with Aurora-A directly in vitro and in vivo. In addition, Aurora-A is a substrate for USP2a in vitro and in vivo. Our study provides a novel mechanism for the role of USP2a in mediating the stability of Aurora-A.
引用
收藏
页码:38960 / 38968
页数:9
相关论文
共 28 条
  • [1] MdmX is a substrate for the deubiquitinating enzyme USP2a
    Allende-Vega, N.
    Sparks, A.
    Lane, D. P.
    Saville, M. K.
    [J]. ONCOGENE, 2010, 29 (03) : 432 - 441
  • [2] AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol
    Anand, S
    Penrhyn-Lowe, S
    Venkitaraman, AR
    [J]. CANCER CELL, 2003, 3 (01) : 51 - 62
  • [3] Aurora kinases: shining lights on the therapeutic horizon?
    Andrews, PD
    [J]. ONCOGENE, 2005, 24 (32) : 5005 - 5015
  • [4] Fatty acid synthase: A metabolic oncogene in prostate cancer?
    Baron, A
    Migita, T
    Tang, D
    Loda, M
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (01) : 47 - 53
  • [5] A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
    Bischoff, JR
    Anderson, L
    Zhu, YF
    Mossie, K
    Ng, L
    Souza, B
    Schryver, B
    Flanagan, P
    Clairvoyant, F
    Ginther, C
    Chan, CSM
    Novotny, M
    Slamon, DJ
    Plowman, GD
    [J]. EMBO JOURNAL, 1998, 17 (11) : 3052 - 3065
  • [6] The cellular geography of aurora kinases
    Carmena, M
    Earnshaw, WC
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (11) : 842 - 854
  • [7] Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas
    da Silva, Sabrina Daniela
    Cunha, Isabela Werneck
    Nishimoto, Ines Nobuko
    Soares, Fernando Augusto
    Carraro, Dirce Maria
    Kowalski, Luiz Paulo
    Graner, Edgard
    [J]. ORAL ONCOLOGY, 2009, 45 (10) : E134 - E139
  • [8] The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
    Graner, E
    Tang, D
    Rossi, S
    Baron, A
    Migita, T
    Weinstein, LJ
    Lechpammer, M
    Huesken, D
    Zimmermann, J
    Signoretti, S
    Loda, M
    [J]. CANCER CELL, 2004, 5 (03) : 253 - 261
  • [9] Hainaut P, 2000, ADV CANCER RES, V77, P81
  • [10] Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells
    Hirota, T
    Kunitoku, N
    Sasayama, T
    Marumoto, T
    Zhang, DW
    Nitta, M
    Hatakeyama, K
    Saya, H
    [J]. CELL, 2003, 114 (05) : 585 - 598